AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
πΏπ²
Mebendazole in Zambia
5 products registered with ZAMRA β 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Mebendazole Tablet Uncoated | 272/027 | MEDOPHARM | active | 13 Dec 2030 |
| Mebendazole oral suspension Suspension for Oral Use | 002/013 | Ciron Drugs & Pharmaceuticals Pvt. Ltd. | active | 12 Dec 2030 |
| Mebendazole Tablets Tablet Chewable | ZAMRA-HM-25-233 | Missionpharma A/S | active | 8 Jul 2030 |
| Tilzole tablets Tablet Uncoated | 238/009 | TIL HEALTHCARE PRIVATE LIMITED | active | 6 Jun 2029 |
| Mebfil suspension Suspension for Oral Use | 177/017 | Fourrts (India) Laboratories (Pvt) Limited | active | 3 Jun 2029 |
Mebendazole β ZAMRA Registration Details
ZAMRA (Zambia) has 5 registered products containing Mebendazole, of which 5 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Mebendazole registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.